Stefan Nikolaus Gradl

This inventor holds 12 USPTO granted patents and 6 published patent applications and 7 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, The Broad Institute, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Nikolaus Gradl. Retrieved from https://idiyas.com/inventor/stefan-nikolaus-gradl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 91.7

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 13.0

ph-index = 3

Forward Citations = 17(Granted Patents)

Company Filing History:

12 out of 12,268

Bayer Aktiengesellschaft

patents

10 out of 387

Bayer Pharma Aktiengesellschaft

patents

10 out of 486

The Broad Institute, Inc.

The General Hospital Corporation

patents

6. 3 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

7. 1 out of 1

Bayer Pharma Aktiegellschaft

patent

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2025-12-02),

2. 12427153 - 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases (2025-09-30),

3. 12258323 - Dihydrooxadiazinones (2025-03-25),

4. 11787797 - 4,5-annulated 1,2,4-triazolones (2023-10-17),

5. 11773070 - Dihydrooxadiazinones (2023-10-03),

6. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2023-08-01),

7. 11427553 - Dihydrooxadiazinones (2022-08-30),

8. 11365179 - Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone (2022-06-21),

9. 11161825 - 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides (2021-11-02),

10. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2021-09-28),

11. 10968216 - 4,5-annulated 1,2,4-triazolones (2021-04-06),

12. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2020-10-27),

Title: Stefan Nikolaus Gradl - Innovative Inventor from Berlin

Introduction: Stefan Nikolaus Gradl is a renowned inventor based in Berlin, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Stefan Nikolaus Gradl holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for cutting-edge technology, Stefan Nikolaus Gradl has successfully brought numerous inventions from concept to reality, revolutionizing industries along the way.

Collaborations: Throughout his career, Stefan Nikolaus Gradl has collaborated with leading research institutions, universities, and innovative companies to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Stefan Nikolaus Gradl's relentless pursuit of innovation and his dedication to creating impactful solutions have established him as a prominent figure in the world of inventions, inspiring the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.